209 related articles for article (PubMed ID: 32269072)
1. Clinical and MRI phenotypes of sarcoidosis-associated myelopathy.
Murphy OC; Salazar-Camelo A; Jimenez JA; Barreras P; Reyes MI; Garcia MA; Moller DR; Chen ES; Pardo CA
Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32269072
[TBL] [Abstract][Full Text] [Related]
2. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
3. Neurosarcoidosis according to Zajicek and Scolding criteria: 15 probable and definite cases, their treatment and outcomes.
Cação G; Branco A; Meireles M; Alves JE; Mateus A; Silva AM; Santos E
J Neurol Sci; 2017 Aug; 379():84-88. PubMed ID: 28716286
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal ultra-extensive transverse myelitis as a manifestation of neurosarcoidosis.
Wang L; Li Y
J Neurol Sci; 2015 Aug; 355(1-2):64-7. PubMed ID: 26027786
[TBL] [Abstract][Full Text] [Related]
5. Two cases of sarcoidosis presenting as longitudinally extensive transverse myelitis.
Scott AM; Yinh J; McAlindon T; Kalish R
Clin Rheumatol; 2018 Oct; 37(10):2899-2905. PubMed ID: 29770929
[TBL] [Abstract][Full Text] [Related]
6. Clinical features of spinal cord sarcoidosis: analysis of 17 neurosarcoidosis patients.
Sakushima K; Yabe I; Nakano F; Yoshida K; Tajima Y; Houzen H; Maruo Y; Sasaki H
J Neurol; 2011 Dec; 258(12):2163-7. PubMed ID: 21553080
[TBL] [Abstract][Full Text] [Related]
7. Distinguishing neurosarcoidosis from multiple sclerosis based on CSF analysis: A retrospective study.
Arun T; Pattison L; Palace J
Neurology; 2020 Jun; 94(24):e2545-e2554. PubMed ID: 32354749
[TBL] [Abstract][Full Text] [Related]
8. Spinal adhesive arachnoiditis mimicking sarcoid myelitis with nodular dural enhancement: A case report.
Clark G; Silbermann E; Seals S; Thiessen J; Nesbit G; Yadav V; Wooliscroft L
Mult Scler Relat Disord; 2020 Sep; 44():102257. PubMed ID: 32535503
[TBL] [Abstract][Full Text] [Related]
9. Discriminating long myelitis of neuromyelitis optica from sarcoidosis.
Flanagan EP; Kaufmann TJ; Krecke KN; Aksamit AJ; Pittock SJ; Keegan BM; Giannini C; Weinshenker BG
Ann Neurol; 2016 Mar; 79(3):437-47. PubMed ID: 26677112
[TBL] [Abstract][Full Text] [Related]
10. Identifying specific myelopathy etiologies in the evaluation of suspected myelitis: A retrospective analysis.
Alkabie S; Casserly CS; Morrow SA; Racosta JM
J Neurol Sci; 2023 Jul; 450():120677. PubMed ID: 37207546
[TBL] [Abstract][Full Text] [Related]
11. Clinical biomarkers differentiate myelitis from vascular and other causes of myelopathy.
Barreras P; Fitzgerald KC; Mealy MA; Jimenez JA; Becker D; Newsome SD; Levy M; Gailloud P; Pardo CA
Neurology; 2018 Jan; 90(1):e12-e21. PubMed ID: 29196574
[TBL] [Abstract][Full Text] [Related]
12. [Inflammatory diseases of the spinal cord and spinal nerve roots in the MRI].
Sartoretti-Schefer S; Wichmann W; Valavanis A
Radiologe; 1996 Nov; 36(11):897-913. PubMed ID: 9036432
[TBL] [Abstract][Full Text] [Related]
13. Spinal Cord Sarcoidosis Occurring at Sites of Spondylotic Stenosis, Mimicking Spondylotic Myelopathy: A Case Series and Review of the Literature.
Kurtz RM; Babatunde VD; Schmitt JE; Berger JR; Mohan S
AJNR Am J Neuroradiol; 2023 Jan; 44(1):105-110. PubMed ID: 36521966
[TBL] [Abstract][Full Text] [Related]
14. [Spinal dural arteriovenous fistula presented with rapidly progressive myelopathy, longitudinally extensive spinal cord lesion, pleocytosis with polymorphonuclear predominance, and decreased cerebrospinal fluid glucose levels: a case report].
Kitazaki Y; Ueno A; Maeda K; Asano R; Miyayama S; Takabatake Y
Rinsho Shinkeigaku; 2020 Oct; 60(10):699-705. PubMed ID: 32893247
[TBL] [Abstract][Full Text] [Related]
15. Neurosarcoidosis: correlation of cerebrospinal fluid findings with diffuse leptomeningeal gadolinium enhancement on MRI and clinical disease activity.
Wengert O; Rothenfusser-Korber E; Vollrath B; Bohner G; Scheibe F; Otto C; Hofmann J; Angstwurm K; Ruprecht K
J Neurol Sci; 2013 Dec; 335(1-2):124-30. PubMed ID: 24071064
[TBL] [Abstract][Full Text] [Related]
16. Identification of specific causes of myelopathy in a large cohort of patients initially diagnosed with transverse myelitis.
Murphy OC; Barreras P; Villabona-Rueda A; Mealy M; Pardo CA
J Neurol Sci; 2022 Nov; 442():120425. PubMed ID: 36191573
[TBL] [Abstract][Full Text] [Related]
17. Etiological, clinical, and radiological features of longitudinally extensive myelopathy in Chinese patients.
Zhang W; Jiao Y; Cui L; Liu L; Zhang L; Jiao J
J Clin Neurosci; 2016 Oct; 32():61-6. PubMed ID: 27526974
[TBL] [Abstract][Full Text] [Related]
18. Imaging findings in spinal sarcoidosis: a report of 18 cases and review of the current literature.
Soni N; Bathla G; Pillenahalli Maheshwarappa R
Neuroradiol J; 2019 Feb; 32(1):17-28. PubMed ID: 30311851
[TBL] [Abstract][Full Text] [Related]
19. Venous hypertensive myelopathy associated with cervical spondylosis.
Okada S; Chang C; Chang G; Yue JJ
Spine J; 2016 Nov; 16(11):e751-e754. PubMed ID: 27293119
[TBL] [Abstract][Full Text] [Related]
20. Diffuse leptomeningeal enhancement in neurosarcoidosis-related longitudinally extensive myelitis.
Abrantes FF; Moraes MPM; Pedroso JL; Barsottini OG
Arq Neuropsiquiatr; 2023 Nov; 81(11):1016-1017. PubMed ID: 37832599
[No Abstract] [Full Text] [Related]
[Next] [New Search]
